Rising Demand for Point-of-Care Molecular Diagnostics in North America Clinical Settings 2034
The North America Point-of-Care Molecular Diagnostics market continues to play a pivotal role in the advancement of rapid diagnostic technologies. The region benefits from a strong healthcare infrastructure, widespread adoption of innovative diagnostic tools, and increasing demand for faster disease … Read more